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Purpose: To present a possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with
systemic non-Hodgkin’s lymphoma.
Case presentation: A 47-year-old woman presented with decreased visual acuity associated with white retinal
lesions in both eyes. A history of pneumonia of unknown aetiology closely preceded the deterioration of vision.
Five years previously the patient was diagnosed with follicular non-Hodgkin’s lymphoma. She was treated with a
chemotherapy regimen comprised of cyclophosphamide, adriamycin, vincristin, and prednisone with later addition
of the anti-CD20 antibody rituximab. She experienced a relapse 19 months later with involvement of the
retroperitoneal lymph nodes, and commenced treatment with rituximab and 90Y-ibritumomab tiuxetan. A second
relapse occurred 22 months after radioimmunotherapy and was treated with a combination of fludarabine,
cyclophosphamide, and mitoxantrone followed by rituximab. The patient experienced no further relapses until the
current presentation (April, 2010).
Pars plana vitrectomy with vitreous fluid analysis was performed in the right eye. PCR testing confirmed the
presence of cytomegalovirus in the vitreous. Atypical lymphoid elements, highly suspicious of malignancy were also
found on cytologic examination. Intravenous foscarnet was administered continually for three weeks, followed by
oral valganciclovir given in a dose of 900 mg twice per day. In addition, the rituximab therapy continued at three
monthly intervals. Nevertheless, cessation of foscarnet therapy was followed by a recurrence of retinitis on three
separate occasions during a 3-month period instigating its reinduction to the treatment regime after each
recurrence.
Conclusions: Cytomegalovirus retinitis is an opportunistic infection found in AIDS patients as well as in bone
marrow and solid organ transplant recipients being treated with systemic immunosuppressive drugs. This case
presents a less common incidence of cytomegalovirus retinitis occurring in a patient with non-Hodgkin’s
lymphoma. We demonstrated a possible coexistence of cytomegalovirus retinitis and intraocular lymphoma in this
particular patient. The final diagnosis was based on clinical manifestations together with the course of uveitis and
its response to treatment alongside the results of vitreous fluid analysis. This report highlights the importance of
intraocular fluid examination in cases with nonspecific clinical manifestations. Such an examination allows for the
detection of simultaneously ongoing ocular diseases of differing aetiologies and enables the prompt initiation of
effective treatment.
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Cytomegalovirus (CMV) retinitis is a severe sight-
threatening disease which predominantly affects patients
with AIDS [1-3]. CMV retinitis may also occur in
patients who are lymphopenic secondary to immunosup-
pressive therapy after bone marrow or solid organ trans-
plantation [4,5]. Unless effective treatment is promptly
initiated, the disease may lead to progressive visual loss
and blindness [6,7].
Generally, immune recovery uveitis (IRU) should be
considered in the differential diagnosis of CMV retinitis.
IRU is an intraocular inflammatory disorder originally
described in individuals with human immunodeficiency
virus (HIV) and inactive cytomegalovirus retinitis follow-
ing highly active antiretroviral therapy. IRU also occurs
in iatrogenically immunosuppressed individuals in the
context of tapering immunosuppressive treatment [8].
This report focuses on a less common case of cyto-
megalovirus retinitis occurring in a patient with systemic
non-Hodgkin’s lymphoma. It presents an incidence of
simultaneous occurrence of cytomegalovirus retinitis and
intraocular manifestation of non-Hodgkin’s lymphoma.
Case presentation
A 47-year-old woman presented with decreased visual
acuity associated with white retinal lesions in both eyes.
A history of pneumonia of unknown aetiology closely
preceded the deterioration of vision. Five years previ-
ously the patient was diagnosed with follicular non-
Hodgkin’s lymphoma (December, 2004). She underwent
eight cycles of combination chemotherapy that included
cyclophosphamide, adriamycin, vincristine and prednis-
one with later addition of the anti-CD20 antibody rituxi-
mab. The patient was in remission for 19 months.
Following a relapse with involvement of the retroperi-
toneal lymph nodes (February, 2007), rituximab and 90Y-
ibritumomab tiuxetan were administered. A second re-
lapse occurred 22 months post radioimmunotherapy
(April, 2009). Four combination cycles of fludarabine,
cyclophosphamide, and mitoxantrone were thenFigure 1 Anterior segment of the eye. A, large keratic precipitates on thundertaken leading to partial remission. Subsequent
therapy included rituximab administered once per
month for four months and once every third month
thereafter. No further relapses were experienced from
April, 2009 to April, 2010.
At presentation (April, 2010), her best-corrected Snel-
len visual acuity (BCVA) was 6/12 in the right eye and
6/9 in the left eye. There were large keratic precipitates
and a mild anterior chamber cellular reaction present in
both eyes (Figure 1). Examination of the fundus revealed
bilateral findings of moderate vitreous opacities, pale
optic discs, retinal necrosis with retinal infiltrates, sev-
eral hemorrhages in the posterior pole and areas of per-
ipheral retinal atrophy. Some vessels displayed extensive
white sheathing providing them with the appearance of
frosted branch angiitis (Figure 2). Despite prophylactic
antiviral therapy (valganciclovir 900 mg twice per day
and valaciclovir 500 mg once per day) and maintenance
treatment with rituximab (800 mg once per three
months), the most likely diagnoses were CMV retinitis
or intraocular non-Hodgkin’s lymphoma. Blood tests
revealed neutropenia (0.9 × 109/L) with a normal
lymphocyte count of 1.2 × 109/L. Serology was negative
for HIV.
Pars plana vitrectomy was performed in the right eye
for both - diagnostic as well as therapeutic purposes
(June, 2010). Vitreous fluid analysis confirmed CMV by
means of PCR testing. Furthermore, cytologic examin-
ation revealed atypical lymphocytes with lobulated nuclei
and basophilic cytoplasma (Figure 3) on a background of
lytic cells. Two specialists confirmed the finding of
highly suspicious malignant elements in the vitreous
fluid. Treatment with intravenous foscarnet was given
continually for three weeks followed by oral valganciclo-
vir given in a dose of 900 mg twice per day. Rituximab
therapy was also maintained and administered every
three months. The diagnosis of intraocular lymphoma is
usually an indication for intravitreal treatment with
methotrexate in addition to systemic therapy. Intavenous
methotrexate therapy was not considered in this case ase corneal endothelium. B, a mild anterior chamber cellular reaction.
Figure 2 A photograph of the fundus. A, right eye. B, left eye. Apparent are retinal infiltrates and retinal necrosis, a pale optic disc, several
hemorrhages in the posterior pole and white sheathing of some vessels.
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virus aetiology. In such infectious cases, methotrexate
could probably worsen the course of ocular disease.
Retinal findings responded well to treatment and retin-
itis regressed. However, BCVA decreased to 6/24 in the
right eye and 6/12 in the left eye, perimetry revealed
scotomas (Figure 4) and moderate vitreous haze per-
sisted in the left eye (Figure 5). The main cause of visual
impairment was most likely pallor of the optic disc.
A relapse of retinitis in the three weeks following dis-
continuation of foscarnet treatment necessitated its rein-
duction and administration once again continually for
three weeks (August, 2010). BCVA reduced to hand
movements in the right eye and 6/18 in the left eye and
further progression of visual field defects was demon-
strated (Figure 6). A further recurrence developed within
one week of cessation of this therapy. Consequently, the
patient was retreated with foscarnet administered as a
bolus three times per week (September, 2010). This
therapeutic regime proved to be insufficient as retinalFigure 3 Results of cytologic examination of vitreous fluid. A, atypical
lymphocytes in vitreous body. Microscope Olympus BX51, digital camera Elesions once again showed signs of reactivation. More-
over, an increase in plasmatic CMV DNA copies was
detected (Figure 7). The patient was admitted to a
hematologic clinic and treatment with intravenous fos-
carnet was administered continually for further three
weeks (October, 2010). Systemic examination for re-
staging of the follicular lymphoma was also undertaken.
An MRI of the brain showed no signs of lymphoma.
Cerebrospinal fluid was negative for CMV. No patho-
logical changes were revealed by immunophenotyping
and cytologic examination of cerebrospinal fluid.
Retinal lesions were in regression, but plasma CMV
DNA copies were still positive giving rise to consider-
ation of cidofovir therapy. The patient declined this
treatment. Maintenance therapy with rituximab was also
discontinued.
Two months after the most recent foscarnet therapy
(December, 2010), negativity of CMV DNA copies in the
plasma was detected. However, BCVA had decreased to
hand movements in the right eye and 1/60 in the left eyelymphocytes highly suspected of NHL. B, syntitium of atypical
-510. Objective 100x, num.ap. 1.4. May-Gruenwald-Giemsa staining.
Figure 4 Results of perimetry. A, right eye. B, left eye. Large visual fields defects.
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Figure 5 Vitreous haze in the left eye.
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sion of cataract.
Patient follow-up was scheduled for every 8-10 weeks
as retinal lesions were inactive (Figure 8). Nevertheless,
moderate vitreous haze remained in the left eye resem-
bling that which occurs in patients with intraocular
lymphoma. It is therefore believed that both CMV retin-
itis and intraocular lymphoma contributed to the intrao-
cular findings. This opinion was strongly supported in
the results of vitreous fluid analysis of the right eye.
Undertaking diagnostic-therapeutic pars plana vitrec-
tomy in the left eye imposed a high risk and the patient
declined this surgical procedure.
In August 2011, trepanobiopsy confirmed a transform-
ation of follicular lymphoma into secondary acute mye-
loid leukemia. Palliative treatment was indicated for this
disease.
At the last follow-up in March 2012, no visual acuity
was recordable in the right eye (blind eye) and hand
movements in the left eye. Bilateral progression of cata-
ract prevented good fundal views although some white
retinal lesions were apparent.
The patient died in another hospital in June 2012
where unfortunately no post-mortem examination was
performed.
Discussion
Cytomegalovirus retinitis commonly presents in im-
munocompromised lymphocytopenic patients, mainly inpatients with AIDS. Occurances of CMV retinitis in im-
munocompetent patients although rare, have been
described [9].
This report presents a case of bilateral CMV retinitis
in an HIV negative patient with non-Hodgkin’s lymph-
oma who had a normal lymphocyte count. Intraocular
inflammation of CMV aetiology occurred despite oral
prophylaxis with valganciclovir. Similar cases have been
published, where valganciclovir prophylaxis or ganciclo-
vir/valganciclovir treatment were unable to prevent
CMV retinitis because of drug resistance [10,11].
It is critical to differentiate lymphomatous chorioret-
inal infiltration from opportunistic CMV infection in
order to obtain an accurate diagnosis and initiate effect-
ive treatment in patients with non-Hodgkin’s lymphoma.
It is well known that the differential diagnosis of such
cases should also include fulminant toxoplasmic chorior-
etinitis, mycotic endophthalmitis, tuberculosis, syphilis,
herpes simplex or varicella zoster retinitis. Where clin-
ical findings are not specific, intraocular fluid/tissue ana-
lysis may be necessary. Derzko-Dzulynsky et al. reported
the case of a patient with follicular non-Hodgkin’s
lymphoma, who developed a chorioretinal infiltrate that
was initially thought to represent an intraocular mani-
festation of malignant disease. The patient received radi-
ation treatment appropriate for intraocular lymphoma.
The lesion progressed further and after re-evaluation,
which included vitreous fluid examination, a diagnosis of
cytomegalovirus retinitis was made and therapy initiated
Figure 6 Perimetry with progression of visual fields defects. A, right eye. B, left eye.
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Figure 7 Time course of CMV DNA copies in plasma. Three-week long continuous intravenous foscarnet was applied in June, July and
October, 2010. During September the patient was treated with foscarnet administered as a bolus three times per week.
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Hodgkin’s lymphoma and retinal infiltrate was described
by Gooi et al. In this patient, CMV retinitis mimicked
intraocular lymphoma and a retinal biopsy was required
for assessment of the final diagnosis [13].
In the case presented here, an initial diagnostic di-
lemma was caused by the clinical appearance of lesions
and subsequent results of vitreous fluid analysis - both
of which provided evidence of CMV retinitis and con-
current intraocular lymphoma. To date, it appears that
similar cases of two coexisting ocular diseases of differ-
ing aetiologies both in an active course – malignant
masquerade syndrome and infectious uveitis, have not
been reported. Thus, this patient was treated by means
of intravenous foscarnet applied continually. However,Figure 8 A photograph of the fundus with retinal lesions in regressio
eye. A pale optic disc and persisting moderate vitreous haze.management of non-Hodgkin’s lymphoma involved only
maintenance treatment with rituximab applied every three
months because of a negative restaging examination.
A therapeutic regime using foscarnet administration as
a bolus three times per week was ineffective and led to a
relapse of retinitis. Hence, continual intravenous applica-
tion was necessary to control CMV retinitis activity. On
the other hand, a study performed in patients with HIV
infection showed that although foscarnet was given as a
continuous intravenous infusion, there was a large vari-
ation in foscarnet concentration in the plasma of
patients [14].
A suspicion remained that the persistent vitreous haze
in the left eye, atypical at this degree for CMV retinitis,
was an intraocular manifestation of non-Hodgkin’sn. A, right eye. A pale optic disc and fibrosis of some vessels. B, left
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declined vitreous fluid analysis.
Conclusions
This case reports a possible coincidence of cytomegalo-
virus retinitis and intraocular lymphoma in a patient
with systemic non-Hodgkin’s lymphoma. The final diag-
nosis was based on clinical manifestations, the course of
uveitis and its response to treatment as well as the
results of vitreous fluid analysis. This report highlights
the importance of intraocular fluid examination, espe-
cially in cases with nonspecific clinical manifestations.
Such an examination allows for detection of simultan-
eous ongoing ocular diseases of two different aetiologies
and thus enables the prompt initiation of effective
treatment.
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